These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12673128)

  • 21. Viral genetic variation, AIDS, and the multistep nature of carcinogenesis: the feline leukemia virus model.
    Rohn JL; Gwynn SR; Lauring AS; Linenberger ML; Overbaugh J
    Leukemia; 1996 Dec; 10(12):1867-9. PubMed ID: 8946923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous retroviruses and cancer.
    Ruprecht K; Mayer J; Sauter M; Roemer K; Mueller-Lantzsch N
    Cell Mol Life Sci; 2008 Nov; 65(21):3366-82. PubMed ID: 18818873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Feline Leukemia Virus Interference Group Based on the env Gene.
    Miyake A; Watanabe S; Hiratsuka T; Ito J; Ngo MH; Makundi I; Kawasaki J; Endo Y; Tsujimoto H; Nishigaki K
    J Virol; 2016 May; 90(9):4832-4837. PubMed ID: 26889025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional interactions between monomers of the retroviral envelope protein complex.
    Zhao Y; Lee S; Anderson WF
    J Virol; 1997 Sep; 71(9):6967-72. PubMed ID: 9261425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between endogenous feline leukemia virus loads and exogenous feline leukemia virus infection in domestic cats.
    Tandon R; Cattori V; Pepin AC; Riond B; Meli ML; McDonald M; Doherr MG; Lutz H; Hofmann-Lehmann R
    Virus Res; 2008 Jul; 135(1):136-43. PubMed ID: 18407367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral causes of feline lymphoma: retroviruses and beyond.
    Beatty J
    Vet J; 2014 Aug; 201(2):174-80. PubMed ID: 24928422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ancestral Mutations Acquired in Refrex-1, a Restriction Factor against Feline Retroviruses, during its Cooption and Domestication.
    Ito J; Baba T; Kawasaki J; Nishigaki K
    J Virol; 2016 Feb; 90(3):1470-85. PubMed ID: 26581999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein.
    Hall FL; Gordon EM; Wu L; Zhu NL; Skotzko MJ; Starnes VA; Anderson WF
    Hum Gene Ther; 1997 Dec; 8(18):2183-92. PubMed ID: 9449372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FeLV vaccination.
    Mainland TR
    Vet Rec; 1993 Nov; 133(20):508. PubMed ID: 8296439
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction.
    Zavorotinskaya T; Albritton LM
    J Virol; 1999 Jul; 73(7):5621-9. PubMed ID: 10364311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes.
    Rigby MA; Rojko JL; Stewart MA; Kociba GJ; Cheney CM; Rezanka LJ; Mathes LE; Hartke JR; Jarrett O; Neil JC
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2839-47. PubMed ID: 1331290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis of Moloney murine leukaemia virus surface protein gp70.
    Skov H; Andersen KB
    J Gen Virol; 1993 Apr; 74 ( Pt 4)():707-14. PubMed ID: 8468556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
    Chandhasin C; Coan PN; Levy LS
    J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replication.
    Poon B; Chen IS
    J Virol; 1998 Mar; 72(3):1959-66. PubMed ID: 9499049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.
    Schnierle BS; Stitz J; Bosch V; Nocken F; Merget-Millitzer H; Engelstädter M; Kurth R; Groner B; Cichutek K
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8640-5. PubMed ID: 9238030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants.
    Lauring AS; Anderson MM; Overbaugh J
    J Virol; 2001 Oct; 75(19):8888-98. PubMed ID: 11533152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domain.
    Faix PH; Feldman SA; Overbaugh J; Eiden MV
    J Virol; 2002 Dec; 76(23):12369-75. PubMed ID: 12414980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A gene therapy model for retrovirus-induced disease with a viral env gene: expression-dependent resistance in immunosuppressed hosts.
    Kitagawa M; Aizawa S; Sado T; Yamaguchi S; Suzuki T; Hirokawa K; Ikeda H
    Leukemia; 2001 Nov; 15(11):1779-84. PubMed ID: 11681421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The critical N-linked glycan of murine leukemia virus envelope protein promotes both folding of the C-terminal domains of the precursor polyprotein and stability of the postcleavage envelope complex.
    Li Z; Pinter A; Kayman SC
    J Virol; 1997 Sep; 71(9):7012-9. PubMed ID: 9261431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.
    Wu BW; Lu J; Gallaher TK; Anderson WF; Cannon PM
    Virology; 2000 Mar; 269(1):7-17. PubMed ID: 10725193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.